Source: Υπουργείο Υγείας (CY) Revision Year: 2018 Publisher: TAD Pharma GmbH, Heinz-Lohmann-Straße 5, D-27472 Cuxhaven, Germany Tel: +49 4721 606 0, Fax: +49 4721 606 333, Email: info@tad.de Distributor: Ki.Pa pharrmacal Ltd, 9, Polygyrou Street PO Box 40608 Larnaca, ...
AmloBe 5 mg tablets.
AmloBe 10 mg tablets.
Pharmaceutical Form |
---|
Tablet. 5 mg tablets: white, round, slightly biconvex, bevel-edged, scored on one side, diameter 8 mm. The tablet can be divided into equal halves. 10 mg tablets: white, round, slightly biconvex, bevel-edged, diameter 10.5 mm. |
AmloBe 5 mg tablets: Each tablet contains 6.94 mg amlodipine besylate equivalent to 5 mg of amlodipine.
AmloBe 10 mg tablets: Each tablet contains 13.88 mg amlodipine besylate equivalent to 10 mg of amlodipine.
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Amlodipine |
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. |
List of Excipients |
---|
Microcristalline cellulose (E460) |
OPA-Al-PVC/Al blister: 30 tablets.
Not all pack sizes may be marketed.
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, D-27472 Cuxhaven, Germany
Tel: +49 4721 606 0, Fax: +49 4721 606 333, Email: info@tad.de
Distributor:
Ki.Pa pharrmacal Ltd, 9, Polygyrou Street PO Box 40608 Larnaca, Cyprus
Tel: +35724651882, Fax: +35724627038
AmloBe 5 mg tablets: 21192
AmloBe 10 mg tablets: 21193
Date of first authorisation: 05.03.2012 / 20/09/2018
Drug | Countries | |
---|---|---|
AMLOBE | Cyprus |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.